Overview
Raphael Escaig practices practicing medicine in Munich, Germany.
His clinical expertise encompasses Infective Endocarditis, Endocarditis, and Mesenteric Venous Thrombosis.
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Raphael Escaig
Is Raphael Escaig a top-rated expert for Infective Endocarditis?
MediFind is an objective health platform that identifies experts based on real-world data. Raphael Escaig is classified as an Experienced expert for Infective Endocarditis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Raphael Escaig participate in research or clinical trials?
Yes. Raphael Escaig has published 13 articles and abstracts on conditions like Infective Endocarditis. You can view a list of Raphael Escaig's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EndocarditisMr. Escaig isExperienced. Learn about Endocarditis.
- Infective EndocarditisMr. Escaig isExperienced. Learn about Infective Endocarditis.
- Mesenteric Venous ThrombosisMr. Escaig isExperienced. Learn about Mesenteric Venous Thrombosis.